4640 Admiralty Way
Suite 500
Marina del Rey, CA 90292
United States
310 496 5744
https://viadermalicensing.com
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Qing Hua Lin | Chief Financial Officer and Director | 4.46k | N/A | 1981 |
Mr. Baotang Zhao | Chief Sales Officer | 28.77k | N/A | 1978 |
Mr. Zhang Xie | Corporate Secretary and Director | 9.18k | N/A | 1979 |
Dr. Christopher A Otiko | Founder, Chief Executive Officer and President | N/A | N/A | N/A |
Dr. Andrew Berman M.D., MPH | Medical Director and Member of Advisory Board | N/A | N/A | N/A |
ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.
ViaDerma, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.